Driehaus Capital Management LLC Albireo Pharma, Inc. Transaction History

Driehaus Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$32.03 - $42.85 $432,405 - $578,475	-13,500 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $3.15 Million - $4.2 Million	-99,670 Reduced 88.07%	13,500 $506,000
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $1.93 Million - $3.46 Million	83,170 Added 277.23%	113,170 $3.78 Million
Q2 2020 Aug 14, 2020	BUY	$14.82 - $29.92 $444,600 - $897,600	30,000 New	30,000 $795,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.